The effects of changing dairy intake on trans and saturated fatty acid levels- results from a randomized controlled study

Nutrition Journal

Volumn 13, Issue 1, 2014, Pages

  Benatar, Jocelyne R ^a   Stewart, Ralph Ah ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Dairy food; Palmitelaidic acid; Randomized controlled study; Saturated fatty acids; Trans fatty acids; Vaccenic acid

Indexed keywords

ALANINE; ARACHIDIC ACID; ARACHIDONIC ACID; CERVONIC ACID; DECANOIC ACID; EICOSADIENOIC ACID; FUMARIC ACID; GAMMA LINOLENIC ACID; HEPTADECANOIC ACID; ICOSATETRAENOIC ACID; LAURIC ACID; LIGNOCERIC ACID; LINOLEIC ACID; MILK FAT; MYRISTELAIDIC ACID; MYRISTIC ACID; OCTANOIC ACID; OLEIC ACID; PALMITELAIDIC ACID; PALMITIC ACID; PALMITOLEIC ACID; PENTADECANOIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEARIC ACID; TRANS FATTY ACID; TRIDECYLIC ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; VACCENIC ACID; FAT INTAKE; FATTY ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DAIRY PRODUCT; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; FOOD INTAKE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; NORMAL HUMAN; PHOSPHOLIPID BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ANALYSIS; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; FAT INTAKE; MIDDLE AGED; MILK;

ADULT; ANIMALS; CARDIOVASCULAR DISEASES; DAIRY PRODUCTS; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; MALE; MIDDLE AGED; MILK; PHOSPHOLIPIDS; TRANS FATTY ACIDS;

EID: 84898549329     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-13-32     Document Type: Article

References (45)

1. World Health Statistics. http://apps.who.int/gho/data/node.main.1?lang=en
2. IDF Diabetes Atlas. http://www.idf.org/diabetesatlas
3. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev 2011 D002137 doi:002110.001002/14651858.CD14002137. pub14651852
4. Trans fatty acids and cardiovascular disease. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC, N Engl J Med 2006 354 1601 1613 10.1056/NEJMra054035 16611951
5. N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis. de Goede J, Verschuren WM, Boer JM, Verberne LD, Kromhout D, Geleijnse JM, PLoS One 2013 8 59408 10.1371/journal.pone.0059408 23741290
6. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: the cardiovascular health study. Lemaitre RN, King IB, Mozaffarian D, Sotoodehnia N, Rea TD, Kuller LH, Tracy RP, Siscovick DS, Circulation 2006 114 209 215 10.1161/CIRCULATIONAHA.106.620336 16818809 (Pubitemid 44297114)
7. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. Khaw KT, Friesen MD, Riboli E, Luben R, Wareham N, PLoS Med 2012 9 1001255 10.1371/journal.pmed. 1001255 22802735
8. Fatty acids in bovine milk fat. Mansson HL, Food Nutr Res 2008 52 10 34
9. Diet, nutrition and the prevention of chronic diseases-Report of the joint WHO/FAO expert consultation. http://www.who.int/dietphysicalactivity/ publications/trs916/summary/en/
10. Distribution of isomeric octadecenoic fatty acids in milk fat. Parodi PW, J Dairy Sci 1976 59 1870 1873 10.3168/jds.S0022-0302(76)84455-4 993407
11. Time to value milk. Elwood PC, Int J Epidemiol 2005 34 1160 1162 10.1093/ije/dyi136 16027143 (Pubitemid 41535565)
12. Health effects of trans-fatty acids: experimental and observational evidence. Mozaffarian D, Aro A, Willett WC, Eur J Clin Nutr 2009 63 Suppl 2 5 S21
13. Human health benefits of vaccenic acid. Field CJ, Blewett HH, Proctor S, Vine D, Appl Physiol Nutr Metab 2009 34 979 991 10.1139/H09-079 19935865
14. Consumption of industrial and ruminant trans fatty acids and risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Bendsen NT, Christensen R, Bartels EM, Astrup A, Eur J Clin Nutr 2011 65 773 783 10.1038/ejcn.2011.34 21427742
15. Intake of ruminant trans fatty acids and risk of coronary heart disease. Jakobsen MU, Overvad K, Dyerberg J, Heitmann BL, Int J Epidemiol 2008 37 173 182 10.1093/ije/dym243 18077475 (Pubitemid 351228626)
16. Survey of the fatty acid composition of retail milk in the United States including regional and seasonal variations. O'Donnell-Megaro AM, Barbano DM, Bauman DE, J Dairy Sci 2011 94 59 65 10.3168/jds.2010-3571 21183017
17. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. Zock PL, Katan MB, J Lipid Res 1992 33 399 410 1569387
18. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, op Reimer WJ S, Vrints C, Wood D, Zamorano JL, Zannad F, Eur Heart J 2012 33 17 1635 1701 22555213
19. Three daily servings of reduced-fat milk: an evidence-based recommendation? Ludwig DS, Willett WC, JAMA Pediatr 2013 1 2
20. US ChooseMyPlate. http://www.choosemyplate.gov/
21. A randomized trial evaluating the effects of change in dairy food consumption on cardio-metabolic risk factors. Benatar JR, Jones E, White H, Stewart RA, Eur J Prev Cardiol 2013 Epub ahead of print
22. Diet History Questionnaire, Version 2.0 http://riskfactor.cancer.gov/ dhq2/
23. US Department of Agriculture. [ http://www.ers.usda.gov/ ]
24. Brands of dairy products in New Zealand. http://www.fonterrafoodservices. co.nz/brands.html?view=brand&id=17
25. Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. Beermann C, Jelinek J, Reinecker T, Hauenschild A, Boehm G, Klor H-U, Lipids Health Dis 2003 2 10 10.1186/1476-511X-2-10 14622442
26. Analysing controlled trials with baseline and follow up measurements. Vickers AJ, Altman DG, BMJ 2001 323 1123 1124 10.1136/bmj.323.7321.1123 11701584 (Pubitemid 33063362)
27. Kutner MH, Nachtsheim CJ, Neter J, Li W, Applied Linear Statistical Models New York, NY: McGraw-Hill/Irwin 5 2004
28. Practical guidelines for multiplicity adjustment in clinical trials. Proschan MA, Waclawiw MA, Control Clin Trials 2000 21 527 539 10.1016/S0197-2456(00)00106-9 11146147 (Pubitemid 32056216)
29. Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Gebauer SK, Chardigny JM, Jakobsen MU, Lamarche B, Lock AL, Proctor SD, Baer DJ, Adv Nutr 2011 2 332 354 10.3945/an.111.000521 22332075
30. Milk composition of Holstein, Jersey, and Brown Swiss cows in response to increasing levels of dietary fat. Carroll SM, DePeters EJ, Taylor SJ, Rosenberg M, Perez-Monti H, Capps VA, Anim Feed Sci Technol 2006 131 451 473 10.1016/j.anifeedsci.2006.06.019 (Pubitemid 44693024)
31. Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Hu FB, Stampfer MJ, Manson JE, Ascherio A, Colditz GA, Speizer FE, Hennekens CH, Willett WC, Am J Clin Nutr 1999 70 1001 1008 10584044
32. Types of dietary fat and risk of coronary heart disease: a critical review. Hu FB, Manson JE, Willett WC, J Am Coll Nutr 2001 20 5 19 10.1080/07315724.2001.10719008 11293467 (Pubitemid 32244959)
33. Biomarkers of dairy intake and the risk of heart disease. Aslibekyan S, Campos H, Baylin A, Nutr Metab Cardiovasc Dis 2012 22 1039 1045 10.1016/j.numecd.2011.02.003 21549582
34. WHO Scientific Update on health consequences of trans fatty acids: introduction. Nishida C, Uauy R, Eur J Clin Nutr 2009 63 Suppl 2 1 S4
35. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. Adults: a cohort study. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS, Ann Int Med 2010 153 790 799 10.7326/0003-4819-153-12-201012210-00005 21173413
36. Trans-fatty acids in New Zealand patients with coronary artery disease. Benatar JR, Gladding P, White HD, Zeng I, Stewart RA, Eur J Cardiovasc Prev Rehabil 2011 18 615 620 10.1177/1741826710389415 21450635
37. Effect of heating and processing methods of milk and dairy products on conjugated Linoleic acid and trans fatty acid Isomer content. Herzallah SM, Humeid MA, Al-Ismail KM, J Dairy Sci 2005 88 1301 1310 10.3168/jds.S0022- 0302(05)72796-X 15778297 (Pubitemid 41431247)
38. Trans fatty acids in a range of UK processed foods. Roe M, Pinchen H, Church S, Elahi S, Walker M, Farron-Wilson M, Buttriss J, Finglas P, Food Chem 2013 140 427 431 10.1016/j.foodchem.2012.08.067 23601386
39. Biological effects of conjugated linoleic acids in health and disease. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G, J Nutr Biochem 2006 17 789 810 10.1016/j.jnutbio.2006.02.009 16650752 (Pubitemid 44738517)
40. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, Palmquist DL, Griinari JM, Am J Clin Nutr 2002 76 504 510 12197992 (Pubitemid 34920825)
41. Effect of a high intake of conjugated linoleic acid on lipoprotein levels in healthy human subjects. Wanders AJ, Brouwer IA, Siebelink E, Katan MB, PLoS One 2010 5 9000 10.1371/journal.pone.0009000 20140250
42. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Chardigny JM, Destaillats F, Malpuech-Brugere C, Moulin J, Bauman DE, Lock AL, Barbano DM, Mensink RP, Bezelgues JB, Chaumont P, Combe N, Cristiani I, Joffre F, German JB, Dionisi F, Boirie Y, Sebedio J, Am J Clin Nutr 2008 87 558 566 18326592 (Pubitemid 351364535)
43. Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Schaefer EJ, Augustin JL, Schaefer MM, Rasmussen H, Ordovas JM, Dallal GE, Dwyer JT, Am J Clin Nutr 2000 71 746 751 10702168 (Pubitemid 30118567)
44. Is it time to abandon the food frequency questionnaire? Kristal AR, Peters U, Potter JD, Cancer Epidemiol Biomarkers Prev 2005 14 2826 2828 10.1158/1055-9965.EPI-12-ED1 16364996 (Pubitemid 43068811)
45. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America's Table Study. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S, Am J Epidemiol 2001 154 1089 1099 10.1093/aje/154.12.1089 11744511 (Pubitemid 33140629)